Results 21 to 30 of about 47 (43)

Binding of recombinant human 125I-erythropoietin to CFU-E from the spleen of anemic mice.

Haematologica, 1990
Erythroid precursors were obtained from the spleen of mice made anemic with phenylhydrazine and used to study the binding of bioactive 125I-rEp to membrane receptors. Kinetic analysis, using splenic cells obtained at different times following the induction of anemia, showed that the maximum binding was reached at day 3, and decreased thereafter ...
VANNUCCHI, ALESSANDRO MARIA, Grossi A, Rafanelli D, Vannucchi L, ROSSI FERRINI, PIER LUIGI   +4 more
openaire   +2 more sources

Abstracts of the 76th Annual Meeting of the Japanese Cancer Association; 2017 Sept 28‐30; Yokohama, Japan

, 2018
Cancer Science, Volume 109, Issue S1, Page 1-1325, January 2018.
wiley   +1 more source

UEG Week 2016 Poster Presentations

, 2016
United European Gastroenterology Journal, Volume 4, Issue S5, Page A157-A720, October 2016.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A dot assay for the erythropoietin receptor using human recombinant 125I-erythropoietin

Analytical Biochemistry, 1989
A dot assay was developed for the detection of membrane receptor(s) for erythropoietin (Ep). A relatively homogeneous population of cells bearing the receptor for Ep was generated in the spleen of mice made anemic with phenylhydrazine and crude membrane extracts were prepared from spleen cell suspensions.
Alessandro Maria Vannucchi, A Grossi, Pierluigi Rossi Ferrini   +2 more
exaly   +4 more sources

In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep.

Journal of Pharmacology and Experimental Therapeutics, 1996
Knowledge regarding the in vivo metabolic fate of the glycoprotein erythropoietin (EPO) is incomplete. To determine whether EPO pharmacokinetics are perturbed by ablation of the kidneys or liver or by anesthesia, EPO pharmacokinetic parameters were determined in adult sheep.
R L Schmidt, J A Widness, P Veng-Pedersen   +2 more
exaly   +3 more sources

Tunicamycin modulates binding of 125I-erythropoietin to Friend erythroleukemia cells.

Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society, 1989
The effects of tunicamycin and neuraminidase treatment on the specific binding of 125I-erythropoietin to a murine erythroleukemia cell clone, B8, were investigated. Neuraminidase treatment of B8 cells did not affect the specific binding of erythropoietin, but tunicamycin treatment caused a 2.5 to 4-fold increase in the amount of 125I-erythropoietin ...
H, Fukamachi, A, Tojo, T, Saito, T, Kitamura, A, Urabe, F, Takaku   +5 more
openaire   +1 more source

STAT5 as a Key Protein of Erythropoietin Signalization

International Journal of Molecular Sciences, 2021
Peter Solar, Peter Solar, Nataša Debeljak   +2 more
exaly  

Plasma Disappearance of 125I-Labeled Erythropoietin in Anesthetized Rabbits

Experimental Biology and Medicine, 1972
J W Fisher
exaly  

The Metabolism of Erythropoietin in the Normal and Uraemic Rabbit

Nephrology Dialysis Transplantation, 1990
M G McGeown, T R Lappin, J M Bridges
exaly  

A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice

Journal of Cerebral Blood Flow and Metabolism, 1999
Myriam Bernaudin, H H Marti, Edwige Petit   +2 more
exaly